Home/Filings/4/0001225208-16-033202
4//SEC Filing

Merck & Co., Inc. 4

Accession 0001225208-16-033202

$MRKCIK 0000310158operating

Filed

May 11, 8:00 PM ET

Accepted

May 12, 11:39 AM ET

Size

8.1 KB

Accession

0001225208-16-033202

Insider Transaction Report

Form 4
Period: 2016-05-10
AMBROSE ADELE D
V-P & Chief Com. Officer
Transactions
  • Award

    Restricted Stock Unit

    2016-05-10+2,7432,743 total
    From: 2019-05-10Exp: 2019-05-10Common Stock (2,743 underlying)
  • Award

    Stock Option (right to buy)

    2016-05-10+33,95633,956 total
    Exercise: $54.68From: 2017-05-10Exp: 2026-05-09Common Stock (33,956 underlying)
Holdings
  • Common Stock

    24,685.178
Footnotes (3)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F3]The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.

Documents

1 file

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000310158

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 11:39 AM ET
Size
8.1 KB